Oncogene - Table of Contents alert Volume 36 Issue 18

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 36, Issue 18 (May 2017) In this issue Review Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Neutrophil extracellular traps: protagonists of cancer progression? L Erpenbeck and M P Schön Oncogene 2017 36: 2483-2490; advance online publication, December 12, 2016; 10.1038/onc.2016.406 Abstract | Full Text Original Articles Top A CDK2 activity signature predicts outcome in CDK2-low cancers S R McCurdy, M Pacal, M Ahmad and R Bremner Oncogene 2017 36: 2491-2502; advance online publication, November 7, 2016; 10.1038/onc.2016.409 Abstract | Full Text The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer OPEN S Omarjee, J Jacquemetton, C Poulard, N Rochel, A Dejaegere, Y Chebaro, I Treilleux, E Marangoni, L Corbo and M Le Romancer Oncogene 2017 36: 2503-2514; advance online publication, December 12, 2016; 10.1038/onc.2016.415 Abstract | Full Text A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis OPEN C J Dunnill, K Ibraheem, A Mohamed, J Southgate and N T Georgopoulos Oncogene 2017 36: 2515-2528; advance online publication, November 21, 2016; 10.1038/onc.2016.401 Abstract | Full Text ROCK2/rasHa co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progression S F Masre, N Rath, M F Olson and D A Greenhalgh Oncogene 2017 36: 2529-2542; advance online publication, December 19, 2016; 10.1038/onc.2016.402 Abstract | Full Text Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling Y-J Kim, K Jung, D-S Baek, S-S Hong and Y-S Kim Oncogene 2017 36: 2543-2552; advance online publication, October 31, 2016; 10.1038/onc.2016.407 Abstract | Full Text Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution M V Puccetti, M A Fischer, M P Arrate, K L Boyd, R J Duszynski, R Bétous, D Cortez and C M Eischen Oncogene 2017 36: 2553-2564; advance online publication, October 31, 2016; 10.1038/onc.2016.408 Abstract | Full Text The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer OPEN C Wilson, L Qiu, Y Hong, T Karnik, G Tadros, B Mau, T Ma, Y Mu, J New, R J Louie, S Gunewardena, A K Godwin, O W Tawfik, J Chien, K F Roby and A J Krieg Oncogene 2017 36: 2565-2576; advance online publication, November 21, 2016; 10.1038/onc.2016.412 Abstract | Full Text Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling OPEN Z-M Shi, L Wang, H Shen, C-F Jiang, X Ge, D-M Li, Y-Y Wen, H-R Sun, M-H Pan, W Li, Y-Q Shu, L-Z Liu, S C Peiper, J He and B-H Jiang Oncogene 2017 36: 2577-2588; advance online publication, February 13, 2017; 10.1038/onc.2016.414 Abstract | Full Text Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia S Goyama, M Shrestha, J Schibler, L Rosenfeldt, W Miller, E O’Brien, B Mizukawa, T Kitamura, J S Palumbo and J C Mulloy Oncogene 2017 36: 2589-2598; advance online publication, November 7, 2016; 10.1038/onc.2016.416 Abstract | Full Text c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun X Xie, T S Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, G B Chauhan, D N Giannoukos, Y Qi, D Tripathy, J Wang, N S Gray, K N Dalby, C Bartholomeusz and N T Ueno Oncogene 2017 36: 2599-2608; advance online publication, December 12, 2016; 10.1038/onc.2016.417 Abstract | Full Text Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway C Urbinati, E Grillo, P Chiodelli, C Tobia, F Caccuri, S Fiorentini, G David and M Rusnati Oncogene 2017 36: 2609-2618; advance online publication, November 7, 2016; 10.1038/onc.2016.420 Abstract | Full Text Short Communication Top CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1 W Zhu, B L Gliddon, K E Jarman, P A B Moretti, T Tin, L V Parise, J M Woodcock, J A Powell, A Ruszkiewicz, M R Pitman and S M Pitson Oncogene 2017 36: 2619-2627; advance online publication, December 12, 2016; 10.1038/onc.2016.428 Abstract | Full Text Corrigendum Top Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis M V Yigit, S K Ghosh, M Kumar, V Petkova, A Kavishwar, A Moore and Z Medarova Oncogene 2017 36: 2628; advance online publication, November 14, 2016; 10.1038/onc.2016.413 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.